Cargando…
[Corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway
Autores principales: | Ji, Junpeng, Shen, Tianyu, Li, Yang, Liu, Yixi, Shang, Zhiqun, Niu, Yuanjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394727/ https://www.ncbi.nlm.nih.gov/pubmed/37477123 http://dx.doi.org/10.3892/or.2023.8602 |
Ejemplares similares
-
CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway
por: Ji, Junpeng, et al.
Publicado: (2021) -
Aberrant KIF20A Expression Is Associated with Adverse Clinical Outcome and Promotes Tumor Progression in Prostate Cancer
por: Zhang, Zheng, et al.
Publicado: (2019) -
Corrigendum to: LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway
Publicado: (2021) -
CDCA8 induced by NF-YA promotes hepatocellular carcinoma progression by regulating the MEK/ERK pathway
por: Chen, Erbao, et al.
Publicado: (2023) -
SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway
por: Luo, Zhenzhen, et al.
Publicado: (2021)